Dapitant

DB20991ExperimentalSmall molecule

Dapitant is a small molecule drug. The usage of the INN stem '-pitant' in the name indicates that Dapitant is a neurokinin NK1 (substance P) receptor antagonist. Dapitant has a... Dapitant has a monoisotopic molecular weight of 561.29 Da.

Formula / weight: C₃₇H₃₉NO₄ · 561.722 g/mol (avg)
Code names: RPR-100893

Resolves to

Compound

UNIINRD5XF638PCAS153438-49-4ChEMBLCHEMBL38824

Structure

InChIKeyCCIWVEMVBWEMCY-RCFOMQFPSA-NSMILES[H][C@@]12CN(C[C@]1([H])C(CC[C@@]2(O)C1=C(OC)C=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1)C(=O)[C@@H](C)C1=C(OC)C=CC=C1

Targets

P25103TACR1

What you can answer from here — as of September 12, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Dapitant, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account